Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:215
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
下载
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [31] Surveillance for hepatocellular carcinoma in chronic hepatitis B virus infection: for whom
    Jihyun An
    Lee, Han Chu
    HEPATIC ONCOLOGY, 2015, 2 (03) : 225 - 229
  • [32] CLINICOPATHOLOGICAL FEATURES OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITHOUT CHRONIC HEPATITIS B VIRUS NOR HEPATITIS C VIRUS INFECTION
    Kondo, Yuichi
    Iimuro, Yuji
    Hirano, Tadamichi
    Hai, Seikan
    Kurimoto, Ami
    Fujimoto, Jiro
    HEPATOLOGY, 2011, 54 : 1399A - 1399A
  • [33] A study into the risk of hepatitis B virus (HBV) reactivation flare after liver resection for hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus infection
    Thia, K
    Lui, HF
    Chung, AY
    Chow, P
    Ooi, LL
    Chow, WC
    HEPATOLOGY, 2005, 42 (04) : 299A - 300A
  • [34] Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden
    Singh, Satender Pal
    Mondia, Nitisha
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (12) : 3592 - 3592
  • [35] Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients
    Rosa, Agatha S.
    Araujo, Oscar C.
    Savassi-Ribas, Flavia
    Fernandes, Carlos A.
    Coelho, Henrique S.
    Niel, Christian
    Villela-Nogueira, Cristiane A.
    Araujo, Natalia M.
    VIRUS RESEARCH, 2017, 242 : 166 - 172
  • [36] Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
    Song, Yusheng
    Chen, Haiyan
    Li, Jinlong
    Zhong, Feifei
    Liu, Yunbing
    Liu, Hui
    Wan, Shaogui
    JOURNAL OF VIRAL HEPATITIS, 2024,
  • [37] Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
    Ohata, K
    Hamasaki, K
    Toriyama, K
    Matsumoto, K
    Saeki, A
    Yanagi, K
    Abiru, S
    Nakagawa, Y
    Shigeno, M
    Miyazoe, S
    Ichikawa, T
    Ishikawa, H
    Nakao, K
    Eguchi, K
    CANCER, 2003, 97 (12) : 3036 - 3043
  • [38] Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Liu, Yanqing
    Mo, Yijun
    Wu, Aihua
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (03) : 573 - 573
  • [39] Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden
    Sundquist, Kristina
    Sundquist, Jan
    Ji, Jianguang
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (01) : 18 - 22
  • [40] Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
    Qi, Peng
    Cheng, Shu-qun
    Wang, Hao
    Li, Nan
    Chen, Yue-feng
    Gao, Chun-fang
    PLOS ONE, 2011, 6 (12):